novavax stock

Business News, Editor's Choice, Market News, News, Stocks

NVAX Stock Rises 7% in Pre-market as Novavax Starts Late-Stage Covid-19 Vaccine Trials in UK

By Godfrey Benjamin Sep 25, 2020

Following the news about the progress with COVID-19 vaccine trials, Novavax shares which closed 0.86% higher on Thursday gained more than 7.33% in the pre-market.

Business News, Market News, News, Stocks

NVAX Stock Up 13%, Novavax Early Trial of COVID-19 Vaccine Shows Stellar Immune Response

By Bhushan Akolkar Aug 5, 2020

Scientists have Novavax’s vaccine results to be impressive and exemplary. If the company gets more leads going ahead, it promises of producing 100 million doses by the start of 2021.

Business News, Editor's Choice, Market News, News, Stocks

NVAX Stock Price Up 35% Now as Novavax Gets $1.6 Billion Grant for COVID-19 Vaccine Development

By Christopher Hamman Jul 7, 2020

NVAX stock price is skyrocketing these days as Novavax is getting one step closer to the development of its coronavirus vaccine.

Business News, Editor's Choice, Investors News, Market News, News

Cruise Companies’ Stocks Rocket as Investors Are Optimistic about Travel Industry Rebound

By Darya Rudz May 27, 2020

Investors are bullish, but this enthusiasm can not help cruise stocks to recover to their former levels immediately. It is possible that it will take years for them to fully recover, even if the companies can sail promptly later this summer. 

Business News, Market News, News, Stocks, Wall Street

NVAX Stock Up 5.7% Now, Novavax CEO Says Coronavirus Workers Could Get Vaccine This Year

By Teuta Franjkovic May 27, 2020

Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate. NVAX stock is up.

Business News, Market News, News, Stocks, Wall Street

NVAX Stock Up Nearly 16% in Pre-market as Novavax Starts Coronavirus Vaccine Trials

By Christopher Hamman May 26, 2020

Novavax (NVAX) has jumped by 16% in the pre-market. The company has announced human trials its COVID-19 vaccine.

Business News, Market News, News, Stocks, Wall Street

Novavax and Moderna Stocks on Rise as Firms Move Further in Coronavirus Vaccine Research

By Steve Muchoki May 18, 2020

Novavax (NVAX) and Moderna (MRNA) stocks remain a buy amid the coronavirus economic disruption. They are 7% and 27% up in the pre-market respectively.

Business News, Market News, News, Stocks

Coronavirus Vaccine Stocks: Top Biotech Companies to Invest In

By Darya Rudz May 18, 2020

Of course, there is always risk involved in investing, regardless of which industry or what kind of company it is. In the case of coronavirus vaccine stocks, you should bear in mind that not all of the vaccine candidates will be successful.

Business News, Market News, News, Stocks, Wall Street

NVAX Stock Jumped 25% Yesterday, Down 15% Now as Novavax Works on COVID-19 Vaccine

By Tolu Ajiboye Apr 21, 2020

Novavax (NVAX) stock climbed 25% yesterday, adding to its current 2020 gains, as the company makes progress on its COVID-19 vaccine candidate. However, today NVAX is 14% down.

Business News, Market News, News, Stocks, Wall Street

Novavax (NVAX) Stock Jumped 6% Yesterday on $4M Funding for Coronavirus Vaccine Trial

By Tolu Ajiboye Mar 11, 2020

Novavax (NVAX) stock jumped again yesterday after it received a $4 million award to be pumped into developing a vaccine for COVID-19. However, today it is falling.

Business News, Market News, News, Stocks

Oil Companies Stock Down as Dow Jones Plummets 1,800 Points, Biotech Stocks Also Bleeding

By Tolu Ajiboye Mar 9, 2020

Dow Jones has lost over 1,880 points due to a row of factors including Saudi’s oil price slash as well as the coronavirus that is quickly spreading. More bleeding is expected.

Business News, Market News, News, Stocks

Inovio (INO) Stock Rises 7.72%, 1 Million Coronavirus Vaccine Doses Expected by Year End

By Tolu Ajiboye Mar 5, 2020

Inovio(INO) stock is enjoying the rally as it put on almost 8% weight days after it announced that it will be speeding up plans for its coronavirus (COVID-19) vaccine.